As expected, AFP and PVIKA-II exhibited limited discriminatory ability when tested at established cutoffs for distinguishing between HCC and cirrhosis (AFP <20 ng/mL, AUC 0.72; PIVKA-II 40 mAU/ml, AUC 0.68) (Table 2). This evidence concerns the gene AFP and hepatocellular carcinoma.